128 related articles for article (PubMed ID: 9628225)
21. Development of an equine-tropic replication-competent lentivirus assay for equine infectious anemia virus-based lentiviral vectors.
Farley DC; Bannister R; Leroux-Carlucci MA; Evans NE; Miskin JE; Mitrophanous KA
Hum Gene Ther Methods; 2012 Oct; 23(5):309-23. PubMed ID: 23121195
[TBL] [Abstract][Full Text] [Related]
22. The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro.
Li F; Puffer BA; Montelaro RC
J Virol; 1998 Oct; 72(10):8344-8. PubMed ID: 9733881
[TBL] [Abstract][Full Text] [Related]
23. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus.
Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ
Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982
[TBL] [Abstract][Full Text] [Related]
24. Transient suppression of equine immune responses by equine infectious anemia virus (EIAV).
Newman MJ; Issel CJ; Truax RE; Powell MD; Horohov DW; Montelaro RC
Virology; 1991 Sep; 184(1):55-66. PubMed ID: 1651604
[TBL] [Abstract][Full Text] [Related]
25. A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus.
Zhang B; Jin S; Jin J; Li F; Montelaro RC
Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9918-23. PubMed ID: 15985554
[TBL] [Abstract][Full Text] [Related]
26. Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein.
Ji S; Na L; Ren H; Wang Y; Wang X
J Virol; 2018 Sep; 92(18):. PubMed ID: 29743377
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a cytolytic strain of equine infectious anemia virus.
Maury W; Wright PJ; Bradley S
J Virol; 2003 Feb; 77(4):2385-99. PubMed ID: 12551976
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of Equine Lentivirus Alters Mitochondrial Protein Expression Profile from Inflammation to Apoptosis.
Du C; Duan Y; Wang XF; Lin Y; Na L; Wang X; Chen K; Wang X
J Virol; 2019 Nov; 93(21):. PubMed ID: 31391270
[TBL] [Abstract][Full Text] [Related]
29. Equine infectious anemia virus replication is upregulated during differentiation of blood monocytes from acutely infected horses.
Sellon DC; Walker KM; Russell KE; Perry ST; Covington P; Fuller FJ
J Virol; 1996 Jan; 70(1):590-4. PubMed ID: 8523576
[TBL] [Abstract][Full Text] [Related]
30. Double-stranded RNA-specific adenosine deaminase 1 (ADAR1) promotes EIAV replication and infectivity.
Tang YD; Na L; Fu LH; Yang F; Zhu CH; Tang L; Li Q; Wang JY; Li Z; Wang XF; Li CY; Wang X; Zhou JH
Virology; 2015 Feb; 476():364-371. PubMed ID: 25589239
[TBL] [Abstract][Full Text] [Related]
31. The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies.
Fagerness AJ; Flaherty MT; Perry ST; Jia B; Payne SL; Fuller FJ
Virology; 2006 May; 349(1):22-30. PubMed ID: 16503341
[TBL] [Abstract][Full Text] [Related]
32. Virulence determinants of equine infectious anemia virus.
Payne SL; Fuller FJ
Curr HIV Res; 2010 Jan; 8(1):66-72. PubMed ID: 20210781
[TBL] [Abstract][Full Text] [Related]
33. Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.
Maury W; Thompson RJ; Jones Q; Bradley S; Denke T; Baccam P; Smazik M; Oaks JL
J Virol; 2005 May; 79(9):5653-64. PubMed ID: 15827180
[TBL] [Abstract][Full Text] [Related]
34. The pathogenic and vaccine strains of equine infectious anemia virus differentially induce cytokine and chemokine expression and apoptosis in macrophages.
Lin YZ; Cao XZ; Li L; Li L; Jiang CG; Wang XF; Ma J; Zhou JH
Virus Res; 2011 Sep; 160(1-2):274-82. PubMed ID: 21782860
[TBL] [Abstract][Full Text] [Related]
35. C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity.
Jiang CG; Gao X; Ma J; Lin YZ; Wang XF; Zhao LP; Hua YP; Liu D; Zhou JH
Virus Res; 2011 Jun; 158(1-2):235-45. PubMed ID: 21539871
[TBL] [Abstract][Full Text] [Related]
36. Immunopathogenesis of equine infectious anemia lentivirus disease.
McGuire TC; O'Rourke KI; Perryman LE
Dev Biol Stand; 1990; 72():31-7. PubMed ID: 2178127
[TBL] [Abstract][Full Text] [Related]
37. The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies.
Li F; Leroux C; Craigo JK; Cook SJ; Issel CJ; Montelaro RC
J Virol; 2000 Jan; 74(1):573-9. PubMed ID: 10590152
[TBL] [Abstract][Full Text] [Related]
38. Endocytosis and a low-pH step are required for productive entry of equine infectious anemia virus.
Brindley MA; Maury W
J Virol; 2005 Dec; 79(23):14482-8. PubMed ID: 16282447
[TBL] [Abstract][Full Text] [Related]
39. Effects of equine infectious anemia virus on hematopoietic progenitors in vitro.
Swardson CJ; Kociba GJ; Perryman LE
Am J Vet Res; 1992 Jul; 53(7):1176-9. PubMed ID: 1323227
[TBL] [Abstract][Full Text] [Related]
40. Equine infectious anemia virus-infected dendritic cells retain antigen presentation capability.
Rivera JA; McGuire TC
Virology; 2005 May; 335(2):145-54. PubMed ID: 15840514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
